Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture - PubMed (original) (raw)
. 1992 Jun 1;79(11):2855-60.
Affiliations
- PMID: 1375116
Free article
Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture
K Tsuji et al. Blood. 1992.
Free article
Abstract
Entry into the cell cycle of dormant hematopoietic progenitors appears to be regulated by multiple synergistic factors, including interleukin-6 (IL-6), granulocyte colony-stimulating factor (G-CSF), IL-11, and the ligand for c-kit, which is also known as steel factor (SF). We have tested the effects of these and other hematopoietic factors on the proliferation of partially enriched dormant murine progenitors in the presence and absence of serum. In serum-containing cultures, SF and IL-11 interacted to support the formation of multilineage colonies; the level of colony formation was comparable with the colony formation supported by other effective two-factor combinations. In serum-free cultures, colony formation supported by two factors was significantly less than that in serum-containing culture and the most effective two-factor combination in serum-free culture was SF plus IL-3. In serum-free cultures, three-factor combinations consisting of SF, IL-3, and one of IL-6, G-CSF, or IL-11 yielded colony formation that was comparable with that seen in serum-containing cultures. These studies indicate that IL-11 belongs to a group of early-acting hematopoietic synergistic factors that now includes IL-6, G-CSF, and IL-11. In contrast, SF is unique among the synergistic factors in that it interacts either with growth factors such as IL-3 or GM-CSF or with synergistic factors such as IL-6, IL-11, or G-CSF.
Similar articles
- Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG. Drexler HG. Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review. - Differentiation and proliferation of hematopoietic stem cells.
Ogawa M. Ogawa M. Blood. 1993 Jun 1;81(11):2844-53. Blood. 1993. PMID: 8499622 Review.
Cited by
- Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression.
Jenkins BJ, Grail D, Inglese M, Quilici C, Bozinovski S, Wong P, Ernst M. Jenkins BJ, et al. Mol Cell Biol. 2004 Feb;24(4):1453-63. doi: 10.1128/MCB.24.4.1453-1463.2004. Mol Cell Biol. 2004. PMID: 14749363 Free PMC article. - An efficient method for single hematopoietic stem cell engraftment in mice based on cell-cycle dormancy of hematopoietic stem cells.
Abe T, Masuya M, Ogawa M. Abe T, et al. Exp Hematol. 2010 Jul;38(7):603-8. doi: 10.1016/j.exphem.2010.03.013. Epub 2010 Mar 28. Exp Hematol. 2010. PMID: 20353809 Free PMC article. - Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction.
Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrison-Smith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA. Hilton DJ, et al. EMBO J. 1994 Oct 17;13(20):4765-75. doi: 10.1002/j.1460-2075.1994.tb06802.x. EMBO J. 1994. PMID: 7957045 Free PMC article. - Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.
Kitoh T, Ishikawa H, Sawada S, Koshino K, Tokano Y, Hashimoto H, Nakagawa S. Kitoh T, et al. Clin Rheumatol. 1998;17(4):293-300. doi: 10.1007/BF01451008. Clin Rheumatol. 1998. PMID: 9776111 - Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras.
Hawley RG, Fong AZ, Ngan BY, de Lanux VM, Clark SC, Hawley TS. Hawley RG, et al. J Exp Med. 1993 Oct 1;178(4):1175-88. doi: 10.1084/jem.178.4.1175. J Exp Med. 1993. PMID: 8104229 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases